By standard isobologram and CompuSyn software analysis we evaluated the combination index (CI) and we found that the combination of sorafenib 10 or 20 μM with perifosine at the doses 1 and 2.5 μM shows synergistic effect increasing the cytotoxicity against T24 BC cells (Fig. 7B).